aluates Reports

$ 0.0

Automative

Global Monoclonal Antibody Biologics and Biosimilars Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-5N13859

Global Monoclonal Antibody Biologics and Biosimilars Market Research Report 2023

BUY CHAPTERS

Global Monoclonal Antibody Biologics and Biosimilars Market Research Report 2025

Code: QYRE-Auto-5N13859

Report

May 2025

Pages:89

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Roche

Amgen Inc

AbbVie

Sanofi

Johnson & Johnson

Pfizer Inc

Eli Lilly

Novartis

Merck

Biogen

Celltrion

SOBI

3SBio Inc

Innovent Biologics

Monoclonal Antibody Biologics and Biosimilars Market Size

The global market for Monoclonal Antibody Biologics and Biosimilars was valued at US$ 258500 million in the year 2024 and is projected to reach a revised size of US$ 565350 million by 2031, growing at a CAGR of 12.0% during the forecast period.

Monoclonal Antibody Biologics and Biosimilars Market

Monoclonal antibodies are immune system proteins that are created in the lab. Antibodies are produced naturally by your body and help the immune system recognize germs that cause disease, such as bacteria and viruses, and mark them for destruction. Like your body’s own antibodies, monoclonal antibodies recognize specific targets.

The monoclonal antibody medicine market is driven by the growing demand for targeted and personalized therapies and the significant advancements in biotechnology and antibody engineering. Monoclonal antibodies (mAbs) offer precise targeting of specific antigens, making them highly effective in treating various diseases, including cancer, autoimmune disorders, and infectious diseases. Their ability to modulate the immune response and their potential for fewer side effects compared to traditional treatments have fueled their popularity among healthcare providers and patients. Moreover, the development of novel mAbs and the expansion of approved indications for existing therapies further contribute to market growth. However, the market also faces challenges, including the high cost of mAb therapies, which can limit patient access and reimbursement. Additionally, the complex manufacturing process and regulatory requirements for mAb medicines can be obstacles for new market entrants. To succeed in this competitive market, manufacturers must focus on improving affordability, exploring biosimilar opportunities, and investing in research and development to develop innovative and differentiated monoclonal antibody medicines that address unmet medical needs.

This report aims to provide a comprehensive presentation of the global market for Monoclonal Antibody Biologics and Biosimilars, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monoclonal Antibody Biologics and Biosimilars.

The Monoclonal Antibody Biologics and Biosimilars market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Monoclonal Antibody Biologics and Biosimilars market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Monoclonal Antibody Biologics and Biosimilars companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Monoclonal Antibody Biologics and Biosimilars Market Report

Report Metric	Details
Report Name	Monoclonal Antibody Biologics and Biosimilars Market
Accounted market size in year	US$ 258500 million
Forecasted market size in 2031	US$ 565350 million
CAGR	12.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Biologics Biosimilars
Segment by Application	Cancer Autoimmune Disease Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Amgen, AbbVie, Sanofi, Johnson & Johnson, Pfizer, Eli Lilly, Novartis, Merck, Biogen, Celltrion, Sobi, 3SBIO, Innovent Biologics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Monoclonal Antibody Biologics and Biosimilars company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Monoclonal Antibody Biologics and Biosimilars Market growing?

Ans: The Monoclonal Antibody Biologics and Biosimilars Market witnessing a CAGR of 12.0% during the forecast period 2025-2031.

What is the Monoclonal Antibody Biologics and Biosimilars Market size in 2031?

Ans: The Monoclonal Antibody Biologics and Biosimilars Market size in 2031 will be US$ 565350 million.

Who are the main players in the Monoclonal Antibody Biologics and Biosimilars Market report?

Ans: The main players in the Monoclonal Antibody Biologics and Biosimilars Market are Roche, Amgen, AbbVie, Sanofi, Johnson & Johnson, Pfizer, Eli Lilly, Novartis, Merck, Biogen, Celltrion, Sobi, 3SBIO, Innovent Biologics

What are the Application segmentation covered in the Monoclonal Antibody Biologics and Biosimilars Market report?

Ans: The Applications covered in the Monoclonal Antibody Biologics and Biosimilars Market report are Cancer, Autoimmune Disease, Other

What are the Type segmentation covered in the Monoclonal Antibody Biologics and Biosimilars Market report?

Ans: The Types covered in the Monoclonal Antibody Biologics and Biosimilars Market report are Biologics, Biosimilars

Recommended Reports

Monoclonal Antibodies

Biosimilars & Biologics

Antibody Drug Technologies

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Monoclonal Antibody Biologics and Biosimilars Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Biologics

1.2.3 Biosimilars

1.3 Market by Application

1.3.1 Global Monoclonal Antibody Biologics and Biosimilars Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Cancer

1.3.3 Autoimmune Disease

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Monoclonal Antibody Biologics and Biosimilars Market Perspective (2020-2031)

2.2 Global Monoclonal Antibody Biologics and Biosimilars Growth Trends by Region

2.2.1 Global Monoclonal Antibody Biologics and Biosimilars Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Monoclonal Antibody Biologics and Biosimilars Historic Market Size by Region (2020-2025)

2.2.3 Monoclonal Antibody Biologics and Biosimilars Forecasted Market Size by Region (2026-2031)

2.3 Monoclonal Antibody Biologics and Biosimilars Market Dynamics

2.3.1 Monoclonal Antibody Biologics and Biosimilars Industry Trends

2.3.2 Monoclonal Antibody Biologics and Biosimilars Market Drivers

2.3.3 Monoclonal Antibody Biologics and Biosimilars Market Challenges

2.3.4 Monoclonal Antibody Biologics and Biosimilars Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Monoclonal Antibody Biologics and Biosimilars Players by Revenue

3.1.1 Global Top Monoclonal Antibody Biologics and Biosimilars Players by Revenue (2020-2025)

3.1.2 Global Monoclonal Antibody Biologics and Biosimilars Revenue Market Share by Players (2020-2025)

3.2 Global Monoclonal Antibody Biologics and Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Monoclonal Antibody Biologics and Biosimilars Revenue

3.4 Global Monoclonal Antibody Biologics and Biosimilars Market Concentration Ratio

3.4.1 Global Monoclonal Antibody Biologics and Biosimilars Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Monoclonal Antibody Biologics and Biosimilars Revenue in 2024

3.5 Global Key Players of Monoclonal Antibody Biologics and Biosimilars Head office and Area Served

3.6 Global Key Players of Monoclonal Antibody Biologics and Biosimilars, Product and Application

3.7 Global Key Players of Monoclonal Antibody Biologics and Biosimilars, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Monoclonal Antibody Biologics and Biosimilars Breakdown Data by Type

4.1 Global Monoclonal Antibody Biologics and Biosimilars Historic Market Size by Type (2020-2025)

4.2 Global Monoclonal Antibody Biologics and Biosimilars Forecasted Market Size by Type (2026-2031)

5 Monoclonal Antibody Biologics and Biosimilars Breakdown Data by Application

5.1 Global Monoclonal Antibody Biologics and Biosimilars Historic Market Size by Application (2020-2025)

5.2 Global Monoclonal Antibody Biologics and Biosimilars Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Monoclonal Antibody Biologics and Biosimilars Market Size (2020-2031)

6.2 North America Monoclonal Antibody Biologics and Biosimilars Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Monoclonal Antibody Biologics and Biosimilars Market Size by Country (2020-2025)

6.4 North America Monoclonal Antibody Biologics and Biosimilars Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Monoclonal Antibody Biologics and Biosimilars Market Size (2020-2031)

7.2 Europe Monoclonal Antibody Biologics and Biosimilars Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Monoclonal Antibody Biologics and Biosimilars Market Size by Country (2020-2025)

7.4 Europe Monoclonal Antibody Biologics and Biosimilars Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Monoclonal Antibody Biologics and Biosimilars Market Size (2020-2031)

8.2 Asia-Pacific Monoclonal Antibody Biologics and Biosimilars Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Monoclonal Antibody Biologics and Biosimilars Market Size by Region (2020-2025)

8.4 Asia-Pacific Monoclonal Antibody Biologics and Biosimilars Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Monoclonal Antibody Biologics and Biosimilars Market Size (2020-2031)

9.2 Latin America Monoclonal Antibody Biologics and Biosimilars Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Monoclonal Antibody Biologics and Biosimilars Market Size by Country (2020-2025)

9.4 Latin America Monoclonal Antibody Biologics and Biosimilars Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Monoclonal Antibody Biologics and Biosimilars Market Size (2020-2031)

10.2 Middle East & Africa Monoclonal Antibody Biologics and Biosimilars Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Monoclonal Antibody Biologics and Biosimilars Market Size by Country (2020-2025)

10.4 Middle East & Africa Monoclonal Antibody Biologics and Biosimilars Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Monoclonal Antibody Biologics and Biosimilars Introduction

11.1.4 Roche Revenue in Monoclonal Antibody Biologics and Biosimilars Business (2020-2025)

11.1.5 Roche Recent Development

11.2 Amgen

11.2.1 Amgen Company Details

11.2.2 Amgen Business Overview

11.2.3 Amgen Monoclonal Antibody Biologics and Biosimilars Introduction

11.2.4 Amgen Revenue in Monoclonal Antibody Biologics and Biosimilars Business (2020-2025)

11.2.5 Amgen Recent Development

11.3 AbbVie

11.3.1 AbbVie Company Details

11.3.2 AbbVie Business Overview

11.3.3 AbbVie Monoclonal Antibody Biologics and Biosimilars Introduction

11.3.4 AbbVie Revenue in Monoclonal Antibody Biologics and Biosimilars Business (2020-2025)

11.3.5 AbbVie Recent Development

11.4 Sanofi

11.4.1 Sanofi Company Details

11.4.2 Sanofi Business Overview

11.4.3 Sanofi Monoclonal Antibody Biologics and Biosimilars Introduction

11.4.4 Sanofi Revenue in Monoclonal Antibody Biologics and Biosimilars Business (2020-2025)

11.4.5 Sanofi Recent Development

11.5 Johnson & Johnson

11.5.1 Johnson & Johnson Company Details

11.5.2 Johnson & Johnson Business Overview

11.5.3 Johnson & Johnson Monoclonal Antibody Biologics and Biosimilars Introduction

11.5.4 Johnson & Johnson Revenue in Monoclonal Antibody Biologics and Biosimilars Business (2020-2025)

11.5.5 Johnson & Johnson Recent Development

11.6 Pfizer

11.6.1 Pfizer Company Details

11.6.2 Pfizer Business Overview

11.6.3 Pfizer Monoclonal Antibody Biologics and Biosimilars Introduction

11.6.4 Pfizer Revenue in Monoclonal Antibody Biologics and Biosimilars Business (2020-2025)

11.6.5 Pfizer Recent Development

11.7 Eli Lilly

11.7.1 Eli Lilly Company Details

11.7.2 Eli Lilly Business Overview

11.7.3 Eli Lilly Monoclonal Antibody Biologics and Biosimilars Introduction

11.7.4 Eli Lilly Revenue in Monoclonal Antibody Biologics and Biosimilars Business (2020-2025)

11.7.5 Eli Lilly Recent Development

11.8 Novartis

11.8.1 Novartis Company Details

11.8.2 Novartis Business Overview

11.8.3 Novartis Monoclonal Antibody Biologics and Biosimilars Introduction

11.8.4 Novartis Revenue in Monoclonal Antibody Biologics and Biosimilars Business (2020-2025)

11.8.5 Novartis Recent Development

11.9 Merck

11.9.1 Merck Company Details

11.9.2 Merck Business Overview

11.9.3 Merck Monoclonal Antibody Biologics and Biosimilars Introduction

11.9.4 Merck Revenue in Monoclonal Antibody Biologics and Biosimilars Business (2020-2025)

11.9.5 Merck Recent Development

11.10 Biogen

11.10.1 Biogen Company Details

11.10.2 Biogen Business Overview

11.10.3 Biogen Monoclonal Antibody Biologics and Biosimilars Introduction

11.10.4 Biogen Revenue in Monoclonal Antibody Biologics and Biosimilars Business (2020-2025)

11.10.5 Biogen Recent Development

11.11 Celltrion

11.11.1 Celltrion Company Details

11.11.2 Celltrion Business Overview

11.11.3 Celltrion Monoclonal Antibody Biologics and Biosimilars Introduction

11.11.4 Celltrion Revenue in Monoclonal Antibody Biologics and Biosimilars Business (2020-2025)

11.11.5 Celltrion Recent Development

11.12 Sobi

11.12.1 Sobi Company Details

11.12.2 Sobi Business Overview

11.12.3 Sobi Monoclonal Antibody Biologics and Biosimilars Introduction

11.12.4 Sobi Revenue in Monoclonal Antibody Biologics and Biosimilars Business (2020-2025)

11.12.5 Sobi Recent Development

11.13 3SBIO

11.13.1 3SBIO Company Details

11.13.2 3SBIO Business Overview

11.13.3 3SBIO Monoclonal Antibody Biologics and Biosimilars Introduction

11.13.4 3SBIO Revenue in Monoclonal Antibody Biologics and Biosimilars Business (2020-2025)

11.13.5 3SBIO Recent Development

11.14 Innovent Biologics

11.14.1 Innovent Biologics Company Details

11.14.2 Innovent Biologics Business Overview

11.14.3 Innovent Biologics Monoclonal Antibody Biologics and Biosimilars Introduction

11.14.4 Innovent Biologics Revenue in Monoclonal Antibody Biologics and Biosimilars Business (2020-2025)

11.14.5 Innovent Biologics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Roche

Amgen Inc

AbbVie

Sanofi

Johnson & Johnson

Pfizer Inc

Eli Lilly

Novartis

Merck

Biogen

Celltrion

SOBI

3SBio Inc

Innovent Biologics

List of Tables

Table 1. Global Monoclonal Antibody Biologics and Biosimilars Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Biologics

Table 3. Key Players of Biosimilars

Table 4. Global Monoclonal Antibody Biologics and Biosimilars Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Monoclonal Antibody Biologics and Biosimilars Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Monoclonal Antibody Biologics and Biosimilars Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Monoclonal Antibody Biologics and Biosimilars Market Share by Region (2020-2025)

Table 8. Global Monoclonal Antibody Biologics and Biosimilars Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Monoclonal Antibody Biologics and Biosimilars Market Share by Region (2026-2031)

Table 10. Monoclonal Antibody Biologics and Biosimilars Market Trends

Table 11. Monoclonal Antibody Biologics and Biosimilars Market Drivers

Table 12. Monoclonal Antibody Biologics and Biosimilars Market Challenges

Table 13. Monoclonal Antibody Biologics and Biosimilars Market Restraints

Table 14. Global Monoclonal Antibody Biologics and Biosimilars Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Monoclonal Antibody Biologics and Biosimilars Market Share by Players (2020-2025)

Table 16. Global Top Monoclonal Antibody Biologics and Biosimilars Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Biologics and Biosimilars as of 2024)

Table 17. Ranking of Global Top Monoclonal Antibody Biologics and Biosimilars Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Monoclonal Antibody Biologics and Biosimilars Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Monoclonal Antibody Biologics and Biosimilars, Headquarters and Area Served

Table 20. Global Key Players of Monoclonal Antibody Biologics and Biosimilars, Product and Application

Table 21. Global Key Players of Monoclonal Antibody Biologics and Biosimilars, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Monoclonal Antibody Biologics and Biosimilars Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Monoclonal Antibody Biologics and Biosimilars Revenue Market Share by Type (2020-2025)

Table 25. Global Monoclonal Antibody Biologics and Biosimilars Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Monoclonal Antibody Biologics and Biosimilars Revenue Market Share by Type (2026-2031)

Table 27. Global Monoclonal Antibody Biologics and Biosimilars Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Monoclonal Antibody Biologics and Biosimilars Revenue Market Share by Application (2020-2025)

Table 29. Global Monoclonal Antibody Biologics and Biosimilars Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Monoclonal Antibody Biologics and Biosimilars Revenue Market Share by Application (2026-2031)

Table 31. North America Monoclonal Antibody Biologics and Biosimilars Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Monoclonal Antibody Biologics and Biosimilars Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Monoclonal Antibody Biologics and Biosimilars Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Monoclonal Antibody Biologics and Biosimilars Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Monoclonal Antibody Biologics and Biosimilars Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Monoclonal Antibody Biologics and Biosimilars Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Monoclonal Antibody Biologics and Biosimilars Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Monoclonal Antibody Biologics and Biosimilars Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Monoclonal Antibody Biologics and Biosimilars Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Monoclonal Antibody Biologics and Biosimilars Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Monoclonal Antibody Biologics and Biosimilars Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Monoclonal Antibody Biologics and Biosimilars Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Monoclonal Antibody Biologics and Biosimilars Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Monoclonal Antibody Biologics and Biosimilars Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Monoclonal Antibody Biologics and Biosimilars Market Size by Country (2026-2031) & (US$ Million)

Table 46. Roche Company Details

Table 47. Roche Business Overview

Table 48. Roche Monoclonal Antibody Biologics and Biosimilars Product

Table 49. Roche Revenue in Monoclonal Antibody Biologics and Biosimilars Business (2020-2025) & (US$ Million)

Table 50. Roche Recent Development

Table 51. Amgen Company Details

Table 52. Amgen Business Overview

Table 53. Amgen Monoclonal Antibody Biologics and Biosimilars Product

Table 54. Amgen Revenue in Monoclonal Antibody Biologics and Biosimilars Business (2020-2025) & (US$ Million)

Table 55. Amgen Recent Development

Table 56. AbbVie Company Details

Table 57. AbbVie Business Overview

Table 58. AbbVie Monoclonal Antibody Biologics and Biosimilars Product

Table 59. AbbVie Revenue in Monoclonal Antibody Biologics and Biosimilars Business (2020-2025) & (US$ Million)

Table 60. AbbVie Recent Development

Table 61. Sanofi Company Details

Table 62. Sanofi Business Overview

Table 63. Sanofi Monoclonal Antibody Biologics and Biosimilars Product

Table 64. Sanofi Revenue in Monoclonal Antibody Biologics and Biosimilars Business (2020-2025) & (US$ Million)

Table 65. Sanofi Recent Development

Table 66. Johnson & Johnson Company Details

Table 67. Johnson & Johnson Business Overview

Table 68. Johnson & Johnson Monoclonal Antibody Biologics and Biosimilars Product

Table 69. Johnson & Johnson Revenue in Monoclonal Antibody Biologics and Biosimilars Business (2020-2025) & (US$ Million)

Table 70. Johnson & Johnson Recent Development

Table 71. Pfizer Company Details

Table 72. Pfizer Business Overview

Table 73. Pfizer Monoclonal Antibody Biologics and Biosimilars Product

Table 74. Pfizer Revenue in Monoclonal Antibody Biologics and Biosimilars Business (2020-2025) & (US$ Million)

Table 75. Pfizer Recent Development

Table 76. Eli Lilly Company Details

Table 77. Eli Lilly Business Overview

Table 78. Eli Lilly Monoclonal Antibody Biologics and Biosimilars Product

Table 79. Eli Lilly Revenue in Monoclonal Antibody Biologics and Biosimilars Business (2020-2025) & (US$ Million)

Table 80. Eli Lilly Recent Development

Table 81. Novartis Company Details

Table 82. Novartis Business Overview

Table 83. Novartis Monoclonal Antibody Biologics and Biosimilars Product

Table 84. Novartis Revenue in Monoclonal Antibody Biologics and Biosimilars Business (2020-2025) & (US$ Million)

Table 85. Novartis Recent Development

Table 86. Merck Company Details

Table 87. Merck Business Overview

Table 88. Merck Monoclonal Antibody Biologics and Biosimilars Product

Table 89. Merck Revenue in Monoclonal Antibody Biologics and Biosimilars Business (2020-2025) & (US$ Million)

Table 90. Merck Recent Development

Table 91. Biogen Company Details

Table 92. Biogen Business Overview

Table 93. Biogen Monoclonal Antibody Biologics and Biosimilars Product

Table 94. Biogen Revenue in Monoclonal Antibody Biologics and Biosimilars Business (2020-2025) & (US$ Million)

Table 95. Biogen Recent Development

Table 96. Celltrion Company Details

Table 97. Celltrion Business Overview

Table 98. Celltrion Monoclonal Antibody Biologics and Biosimilars Product

Table 99. Celltrion Revenue in Monoclonal Antibody Biologics and Biosimilars Business (2020-2025) & (US$ Million)

Table 100. Celltrion Recent Development

Table 101. Sobi Company Details

Table 102. Sobi Business Overview

Table 103. Sobi Monoclonal Antibody Biologics and Biosimilars Product

Table 104. Sobi Revenue in Monoclonal Antibody Biologics and Biosimilars Business (2020-2025) & (US$ Million)

Table 105. Sobi Recent Development

Table 106. 3SBIO Company Details

Table 107. 3SBIO Business Overview

Table 108. 3SBIO Monoclonal Antibody Biologics and Biosimilars Product

Table 109. 3SBIO Revenue in Monoclonal Antibody Biologics and Biosimilars Business (2020-2025) & (US$ Million)

Table 110. 3SBIO Recent Development

Table 111. Innovent Biologics Company Details

Table 112. Innovent Biologics Business Overview

Table 113. Innovent Biologics Monoclonal Antibody Biologics and Biosimilars Product

Table 114. Innovent Biologics Revenue in Monoclonal Antibody Biologics and Biosimilars Business (2020-2025) & (US$ Million)

Table 115. Innovent Biologics Recent Development

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

Table 119. Authors List of This Report

List of Figures

Figure 1. Monoclonal Antibody Biologics and Biosimilars Picture

Figure 2. Global Monoclonal Antibody Biologics and Biosimilars Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Monoclonal Antibody Biologics and Biosimilars Market Share by Type: 2024 VS 2031

Figure 4. Biologics Features

Figure 5. Biosimilars Features

Figure 6. Global Monoclonal Antibody Biologics and Biosimilars Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Monoclonal Antibody Biologics and Biosimilars Market Share by Application: 2024 VS 2031

Figure 8. Cancer Case Studies

Figure 9. Autoimmune Disease Case Studies

Figure 10. Other Case Studies

Figure 11. Monoclonal Antibody Biologics and Biosimilars Report Years Considered

Figure 12. Global Monoclonal Antibody Biologics and Biosimilars Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Monoclonal Antibody Biologics and Biosimilars Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Monoclonal Antibody Biologics and Biosimilars Market Share by Region: 2024 VS 2031

Figure 15. Global Monoclonal Antibody Biologics and Biosimilars Market Share by Players in 2024

Figure 16. Global Top Monoclonal Antibody Biologics and Biosimilars Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Biologics and Biosimilars as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Monoclonal Antibody Biologics and Biosimilars Revenue in 2024

Figure 18. North America Monoclonal Antibody Biologics and Biosimilars Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Monoclonal Antibody Biologics and Biosimilars Market Share by Country (2020-2031)

Figure 20. United States Monoclonal Antibody Biologics and Biosimilars Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Monoclonal Antibody Biologics and Biosimilars Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Monoclonal Antibody Biologics and Biosimilars Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Monoclonal Antibody Biologics and Biosimilars Market Share by Country (2020-2031)

Figure 24. Germany Monoclonal Antibody Biologics and Biosimilars Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Monoclonal Antibody Biologics and Biosimilars Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Monoclonal Antibody Biologics and Biosimilars Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Monoclonal Antibody Biologics and Biosimilars Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Monoclonal Antibody Biologics and Biosimilars Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Monoclonal Antibody Biologics and Biosimilars Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Monoclonal Antibody Biologics and Biosimilars Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Monoclonal Antibody Biologics and Biosimilars Market Share by Region (2020-2031)

Figure 32. China Monoclonal Antibody Biologics and Biosimilars Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Monoclonal Antibody Biologics and Biosimilars Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Monoclonal Antibody Biologics and Biosimilars Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Monoclonal Antibody Biologics and Biosimilars Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Monoclonal Antibody Biologics and Biosimilars Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Monoclonal Antibody Biologics and Biosimilars Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Monoclonal Antibody Biologics and Biosimilars Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Monoclonal Antibody Biologics and Biosimilars Market Share by Country (2020-2031)

Figure 40. Mexico Monoclonal Antibody Biologics and Biosimilars Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Monoclonal Antibody Biologics and Biosimilars Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Monoclonal Antibody Biologics and Biosimilars Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Monoclonal Antibody Biologics and Biosimilars Market Share by Country (2020-2031)

Figure 44. Turkey Monoclonal Antibody Biologics and Biosimilars Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Monoclonal Antibody Biologics and Biosimilars Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Monoclonal Antibody Biologics and Biosimilars Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Roche Revenue Growth Rate in Monoclonal Antibody Biologics and Biosimilars Business (2020-2025)

Figure 48. Amgen Revenue Growth Rate in Monoclonal Antibody Biologics and Biosimilars Business (2020-2025)

Figure 49. AbbVie Revenue Growth Rate in Monoclonal Antibody Biologics and Biosimilars Business (2020-2025)

Figure 50. Sanofi Revenue Growth Rate in Monoclonal Antibody Biologics and Biosimilars Business (2020-2025)

Figure 51. Johnson & Johnson Revenue Growth Rate in Monoclonal Antibody Biologics and Biosimilars Business (2020-2025)

Figure 52. Pfizer Revenue Growth Rate in Monoclonal Antibody Biologics and Biosimilars Business (2020-2025)

Figure 53. Eli Lilly Revenue Growth Rate in Monoclonal Antibody Biologics and Biosimilars Business (2020-2025)

Figure 54. Novartis Revenue Growth Rate in Monoclonal Antibody Biologics and Biosimilars Business (2020-2025)

Figure 55. Merck Revenue Growth Rate in Monoclonal Antibody Biologics and Biosimilars Business (2020-2025)

Figure 56. Biogen Revenue Growth Rate in Monoclonal Antibody Biologics and Biosimilars Business (2020-2025)

Figure 57. Celltrion Revenue Growth Rate in Monoclonal Antibody Biologics and Biosimilars Business (2020-2025)

Figure 58. Sobi Revenue Growth Rate in Monoclonal Antibody Biologics and Biosimilars Business (2020-2025)

Figure 59. 3SBIO Revenue Growth Rate in Monoclonal Antibody Biologics and Biosimilars Business (2020-2025)

Figure 60. Innovent Biologics Revenue Growth Rate in Monoclonal Antibody Biologics and Biosimilars Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Monoclonal Antibody Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Monoclonal antibodies mAbs Biosimilars Market Research Report 2024

Global Antibody Production Services Market Research Report 2024

Global Therapeutic Monoclonal Antibodies Market Research Report 2024

Global Antibody Market Insights Forecast to 2030

Global Cancer Monoclonal Antibody Partnering Terms and Agreements Market Insights Forecast to 2030

Global Anti HA Antibody Market Research Report 2024

Global Monoclonal Antibody Drugs for Cancer Market Research Report 2024

Global Therapeutic Monoclonal Antibodies Drug Market Research Report 2024

Global Arthritis Monoclonal Antibodies Market Research Report 2024

Global Antibody Drugs Market Insights Forecast to 2030

Global Autoantibody Kit Market Insights Forecast to 2030

Adalimumab Monoclonal Antibody Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Monoclonal Mouse Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antibody Therapeutics and Blood Antibody Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Biologics and Biosimilars Market Research Report 2025

Global Combination Antibody Therapy Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions